BLC
JAZZ icon

Brown, Lisle/Cummings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brown, Lisle/Cummings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89K Buy
+10
New +$1.75K ﹤0.01% 835

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Brown, Lisle/Cummings's JAZZ Position: Q1 2026 in Review

Brown, Lisle/Cummings opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 10 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #835 among its holdings.

574 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Brown, Lisle/Cummings held 10 shares of Jazz Pharmaceuticals worth $1.89K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Brown, Lisle/Cummings position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #835 holding.
  • 574 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.